Latest papers
What changed, why it matters, and where the evidence is still thin.
Newsletter · Early access
A concise signal for surgeons, clinicians, researchers, and engineers who want to follow the field without following everything.
What to expect
What changed, why it matters, and where the evidence is still thin.
One concept translated for a clinical audience.
New releases, access changes, and annotation details worth knowing.
Useful technical work explained without product theater.
Calls for expertise, collaboration, events, and ways to participate.